HomeWebcastParagraph IV Patent Litigation in the 2019 Landscape: Trends and Significant Developments Explored!
Online CLE Paragraph IV CLE

Paragraph IV Patent Litigation in the 2019 Landscape: Trends and Significant Developments Explored!

Live Webcast Date: Wednesday, April 10, 2019 from 3:00 pm to 4:00 pm (ET)
CLE Intellectual Property LawRecording

Online CLE Paragraph IV

Join us for this Knowledge Group Online CLE Paragraph IV Webinar. In recent years, generic drug manufacturers have been grappling with filing Paragraph IV (PIV) challenges to successfully gain market entry. The significant increase in the number of patent challenges on brand drugs, specifically on blockbuster drugs, is expected to continue in 2019. However, with the evolving regulatory paradigm, manufacturers become vulnerable to a myriad of risks, including the likelihood of a PIV lawsuit.

In the changing PIV landscape, it is imperative that pharmaceutical companies are abreast of the latest developments to avoid patent infringement, more so, the complexities of a PIV litigation. They must be well-versed with the litigation know-hows to efficiently and effectively win a PIV dispute.

Listen as a panel of distinguished professionals and thought leaders assembled by The Knowledge Group provide an in-depth discussion of the significant trends and developments in Paragraph IV Patent Litigation. Speakers will also offer best strategies that will help manufacturers and counsel in this evolving landscape. 

Key issues that will be covered in this course are:

  • Paragraph IV Patent Litigation and the Abbreviated New Drug Application (ANDA): Recent Trends and Developments
  • Notable PIV Cases and Court Rulings
  • Best Application Strategies
  • Significant Litigation Techniques
  • What Lies Ahead

Agenda

SEGMENT 1:
Philip L. Hirschhorn, Shareholder
Buchanan Ingersoll & Rooney PC
  • The intersection between Hatch-Waxman litigations and proceedings at the PTAB
  • Section 101 and pharma patents in Hatch-Waxman litigations

SEGMENT 2:
Luke T. Shannon, Shareholder
Polsinelli PC
  • Continued presence of patent claims directed to solid forms
  • Anticipation challenges to solid form claims: considerations explored
  • Obviousness challenges to solid form claims: current state of the law

Who Should Attend

  • Patent Attorneys
  • Pharma Industry Lawyers
  • Patent Licensing Attorneys
  • FDA Attorneys
  • Patent Litigators
  • Patent Consultants
  • Pharmaceutical Company Executives
  • Professionals coming from Biotech and Pharmaceutical Firms
  • Professionals coming from Food and Drug Industries
  • Drug Manufacturing Executives
  • Other Related/Interested Professionals

Preview Podcast

Please click the podcast below to hear the speakers discuss the key topics for this webcast.

Online CLE Paragraph IV

SEGMENT 1:
Philip L. Hirschhorn, Shareholder
Buchanan Ingersoll & Rooney PC
  • The intersection between Hatch-Waxman litigations and proceedings at the PTAB
  • Section 101 and pharma patents in Hatch-Waxman litigations

SEGMENT 2:
Luke T. Shannon, Shareholder
Polsinelli PC
  • Continued presence of patent claims directed to solid forms
  • Anticipation challenges to solid form claims: considerations explored
  • Obviousness challenges to solid form claims: current state of the law

Online CLE Paragraph IV

Online CLE Paragraph IV

Philip L. HirschhornShareholderBuchanan Ingersoll & Rooney PC

Phil has more than 25 years' experience as an intellectual property (IP) trial lawyer.  His extensive experience includes bench and jury trials and arbitrations. He has represented clients in Hatch-Waxman (Paragraph IV) litigations, has worked in diverse industries such as graphics, visualization technologies, medical device, chemical and consumer products, and also has experience handling copyright and trademark/trade dress litigation.

In patent litigation, Phil has counseled clients on the interplay between Patent Office and district court proceedings. He has represented clients involved in proceedings in or with the Patent Office, including § 145 actions to obtain patents, ex parte and inter partes reexaminations and, with the advent of the America Invents Act, adversarial post-grant proceedings, including inter partes reviews.

Phil is the managing shareholder for Buchanan's New York City office and the former co-chair of the firm's IP Section.

Online CLE Paragraph IV

Luke T. ShannonShareholderPolsinelli PC

Luke T. Shannon is a shareholder in the Chicago office of Polsinelli PC and a member of the firm’s Hatch-Waxman Litigation Practice Group. Luke has been practicing for more than a decade and handles all types of IP disputes.  His recent focus includes cases involving small molecules, compositions and formulations, polymorphs, combinatorial chemistry, methods of treatment, and pharmaceutical salt forms.

Online CLE Paragraph IV

Course Level:
   Intermediate

Advance Preparation:
   Print and review course materials

Method Of Presentation:
   On-demand Webcast

Prerequisite:
   General knowledge of patent

Course Code:
   147951

NY Category of CLE Credit:
   Areas of Professional Practice

Total Credit:
    1.0 CLE

No Access

You are not logged in. Please or register to the event to gain access to the materials and login instructions.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

Buchanan is a national law firm with a strong reputation for providing progressive, industry-leading legal, business, regulatory and government relations advice to our regional, national and international clients. Our 450 attorneys and government relations professionals across 17 offices proudly represent some of the highest profile and innovative companies in the nation, including 50 of the Fortune 100.  While we service a wide range of clients, Buchanan has especially deep experience in the energy, finance, healthcare and life sciences industries. We bring to our clients an intimate knowledge of the players, market forces and political and regulatory landscape and use our full-service offerings to protect, defend and advance our clients’ businesses.

Website: https://www.bipc.com/

Polsinelli is an Am Law 100 firm with more than 825 attorneys in 21 offices. Ranked #30 for Client Service Excellence  and #10 for best client relationships  among 650 U.S. law firms, Polsinelli was also named among the top 30 best-known firms in the nation . The firm’s attorneys provide value through practical legal counsel infused with business insight, and focus on health care, financial services, real estate, intellectual property, mid-market corporate, labor and employment, and business litigation.

Website: https://www.polsinelli.com/

Phil has more than 25 years' experience as an intellectual property (IP) trial lawyer.  His extensive experience includes bench and jury trials and arbitrations. He has represented clients in Hatch-Waxman (Paragraph IV) litigations, has worked in diverse industries such as graphics, visualization technologies, medical device, chemical and consumer products, and also has experience handling copyright and trademark/trade dress litigation.

In patent litigation, Phil has counseled clients on the interplay between Patent Office and district court proceedings. He has represented clients involved in proceedings in or with the Patent Office, including § 145 actions to obtain patents, ex parte and inter partes reexaminations and, with the advent of the America Invents Act, adversarial post-grant proceedings, including inter partes reviews.

Phil is the managing shareholder for Buchanan's New York City office and the former co-chair of the firm's IP Section.

Luke T. Shannon is a shareholder in the Chicago office of Polsinelli PC and a member of the firm’s Hatch-Waxman Litigation Practice Group. Luke has been practicing for more than a decade and handles all types of IP disputes.  His recent focus includes cases involving small molecules, compositions and formulations, polymorphs, combinatorial chemistry, methods of treatment, and pharmaceutical salt forms.

Ultimate Value Annual Program

Bring a colleague for only $149, a savings of $50 per additional attendee.

  • Unlimited Access to Live & Recorded Webcasts
  • Instant Access to Course Materials
  • And More!

$199